- Home
- SNCY vs LAB Comparison
SNCY vs LAB Comparison
Compare SNCY & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNCY
- LAB
- Stock Information
- Founded
- SNCY 1982
- LAB 1999
- Country
- SNCY United States
- LAB United States
- Employees
- SNCY N/A
- LAB N/A
- Industry
- SNCY Air Freight/Delivery Services
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- SNCY Consumer Discretionary
- LAB Industrials
- Exchange
- SNCY Nasdaq
- LAB Nasdaq
- Market Cap
- SNCY 549.7M
- LAB 473.2M
- IPO Year
- SNCY 2021
- LAB 2011
- Fundamental
- Price
- SNCY $13.20
- LAB $1.41
- Analyst Decision
- SNCY Buy
- LAB Buy
- Analyst Count
- SNCY 7
- LAB 2
- Target Price
- SNCY $17.43
- LAB $2.50
- AVG Volume (30 Days)
- SNCY 885.9K
- LAB 1.2M
- Earning Date
- SNCY 10-29-2025
- LAB 10-29-2025
- Dividend Yield
- SNCY N/A
- LAB N/A
- EPS Growth
- SNCY 20.75
- LAB N/A
- EPS
- SNCY 1.07
- LAB N/A
- Revenue
- SNCY $1,100,145,000.00
- LAB $172,271,000.00
- Revenue This Year
- SNCY $6.07
- LAB N/A
- Revenue Next Year
- SNCY $10.60
- LAB N/A
- P/E Ratio
- SNCY $12.35
- LAB N/A
- Revenue Growth
- SNCY 3.76
- LAB 76.33
- 52 Week Low
- SNCY $8.10
- LAB $0.92
- 52 Week High
- SNCY $18.59
- LAB $2.32
- Technical
- Relative Strength Index (RSI)
- SNCY 54.90
- LAB 60.55
- Support Level
- SNCY $12.61
- LAB $1.27
- Resistance Level
- SNCY $13.43
- LAB $1.41
- Average True Range (ATR)
- SNCY 0.62
- LAB 0.08
- MACD
- SNCY -0.05
- LAB 0.01
- Stochastic Oscillator
- SNCY 42.37
- LAB 95.45
About SNCY Sun Country Airlines Holdings Inc.
Sun Country Airlines Holdings Inc operates low-cost air carriers. The business has two operating segments: Passenger and Cargo. The passenger segment has two internal passenger groups Scheduled service and Charter. The Cargo segment provides air cargo services. The majority of the revenue is from the passenger segment.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.